Skip to content
zameds

Pethidine (Pethidine Intramed)

Pethidine

Bodene (Pty) Ltd Trading As Intramed

Every registration of this product has been cancelled.

Registration

Applicant
Bodene (Pty) Ltd Trading As Intramed
Registrations
4

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Pethidine intramed 50 mg/ml

EACH 1 ml CONTAINS PETHIDINE HYDROCHLORIDE 50 mg

50 mg/mlB0997B/2.9/997CancelledNot determinedNone
Pethidine intramed 100 mg/2 ML

EACH 2 ml AMPOULE CONTAINS PETHIDINE HYDROCHLORIDE 100 mg

100 mg/2 mlB1635B/2.9/1635CancelledNot determinedNone
Pethidine intramed 25 mg/0,5 ML

EACH 0,5 ml AMPOULE CONTAINS PETHIDINE HYDROCHLORIDE 25 mg

25 mg/0,5 mlK0041K/2.9/41CancelledNot determinedNone
Pethidine intramed 75 mg/1,5 ML

EACH 1,5 ml CONTAINS PETHIDINE HYDROCHLORIDE 75 mg

75 mg/1,5 mlK0042K/2.9/42CancelledNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S6: Pethidine

    • pethidine-intermediate A, pethidine-intermediate B and pethidine-intermediate C.

    Consolidated Schedules 06 July 2026, line 10371

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C15H21NO2247.33 g/mol

Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate

Drag to rotate. Structure from PubChem CID 4058.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles